Skip to content
rjbeck77 posted:
This is a letter from Purdue Pharma.

October 4, 2010

Dear Healthcare Professional:
On April 5, 2010, the U.S. Food and Drug Administration (FDA) approved Purdue Pharma
New Drug Application for a reformulation of 80mg OxyContin
® (oxycodone hydrochloride
controlled-release) Tablets. Purdue elected to reformulate OxyContin to be bioequivalent to
the original formulation and in an effort to make the tablet more difficult to manipulate for
the purpose of intentional misuse and abuse, however, there is no evidence that the
reformulation of OxyContin is less subject to misuse, abuse, diversion, overdose, or addiction.
Since introducing reformulated OxyContin to the market on August 9, 2010, Purdue has
received reports that some patients are encountering diffi culties with swallowing
the reformulated tablet. Purdue encourages you to counsel your patients on
appropriately taking this medication and to remind them that:
"022 OxyContin Tablets should be taken one tablet at a time, with enough water to
ensure complete swallowing immediately after placing in the mouth
"022 Multiple tablets should not be swallowed together
"022 Tablets should not be dampened, soaked, licked, or otherwise wet prior to
placing them in the mouth for immediate swallowing

Regards RB

Featuring Experts

Peter Abaci, MD , is certified in anesthesia and pain management by the American Board of Anesthesiology. Dr. Abaci received his undergraduate educat...More

Helpful Tips

I have been on the same pain medication with no change and all of the sudden I can't stay awake and am losing weight. Has anyone else had ... More
Was this Helpful?
2 of 13 found this helpful

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.